Glen C. MacDonald

1.3k total citations
32 papers, 1.1k citations indexed

About

Glen C. MacDonald is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Glen C. MacDonald has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Glen C. MacDonald's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Toxin Mechanisms and Immunotoxins (12 papers) and T-cell and B-cell Immunology (8 papers). Glen C. MacDonald is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Toxin Mechanisms and Immunotoxins (12 papers) and T-cell and B-cell Immunology (8 papers). Glen C. MacDonald collaborates with scholars based in United States, Canada and Netherlands. Glen C. MacDonald's co-authors include Arnold H. Greenberg, Jeannick Cizeau, Joycelyn Entwistle, Judy Lieberman, Christine Vande Velde, Lianfa Shi, John G. Gartner, Hideaki Hara, Klaus Fink and Valeria Gagliardini and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Glen C. MacDonald

31 papers receiving 1.1k citations

Peers

Glen C. MacDonald

IMMUN

ONCOL

RNMI

SURGE

Yves Chicheportiche Switzerland

Annette L. Rothermel United States

Rong Xiang China

Jay Myers United States

Sirous Zeinali Iran

Marı́a J. Calzada Spain

Sridevi Gottipati United States

Cariel Taylor-Edwards United States

Mary Kay Francis United States

Floyd E. Fox United States

Yves Chicheportiche Switzerland

Glen C. MacDonald

813 ×1.4

767 ×1.7

IMMUN

158 ×1.1

ONCOL

177 ×1.4

RNMI

73 ×0.6

SURGE

Citations per year, relative to Glen C. MacDonald Glen C. MacDonald (= 1×) peers Yves Chicheportiche

Countries citing papers authored by Glen C. MacDonald

Since Specialization

Citations

This map shows the geographic impact of Glen C. MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen C. MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen C. MacDonald more than expected).

Fields of papers citing papers by Glen C. MacDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen C. MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen C. MacDonald. The network helps show where Glen C. MacDonald may publish in the future.

Co-authorship network of co-authors of Glen C. MacDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Glen C. MacDonald. A scholar is included among the top collaborators of Glen C. MacDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen C. MacDonald. Glen C. MacDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boogerd, Leonora S. F., Martin C. Boonstra, Hendrica A.J.M. Prevoo, et al.. (2018). Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation. Surgical Oncology. 28. 1–8. 29 indexed citations

Dillon, Rachelle L., et al.. (2017). Abstract 79: Trastuzumab and C6.5 diabody armed with deBouganin overcome drug resistance to ADCs comprised of anti-microtubule agents. Cancer Research. 77(13_Supplement). 79–79. 1 indexed citations

Dillon, Rachelle L., et al.. (2016). Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance. Journal of Immunotherapy. 39(3). 117–126. 19 indexed citations

Entwistle, Joycelyn, et al.. (2012). Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 582–592. 19 indexed citations

Cizeau, Jeannick, et al.. (2011). Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation. Protein Expression and Purification. 78(1). 27–37. 11 indexed citations

Brown, Jennifer G., Michèle Rasamoelisolo, Maureen Spearman, et al.. (2009). Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration. Cancer Biotherapy and Radiopharmaceuticals. 24(4). 477–487. 14 indexed citations

Cizeau, Jeannick, et al.. (2009). Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin. Journal of Immunotherapy. 32(6). 574–584. 63 indexed citations

Brown, Jennifer G., et al.. (2008). Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate. Cancer Research. 68. 2136–2136. 1 indexed citations

MacDonald, Glen C., et al.. (2008). A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck. Medical Oncology. 26(3). 257–264. 20 indexed citations

10.

Cizeau, Jeannick, et al.. (2006). VB1-008: Identification of a fully-human antibody specific for CD44E and CD44-isoform-3. Cancer Research. 66. 682–682.

11.

Entwistle, Joycelyn, et al.. (2006). A targeted proteomic approach for the identification of tumor-associated membrane antigens using the ProteomeLab™ PF-2D in tandem with mass spectrometry. Biochemical and Biophysical Research Communications. 348(3). 1055–1062. 5 indexed citations

12.

Maldonado, Michael A., V.N. Kakkanaiah, Glen C. MacDonald, et al.. (1999). The Role of Environmental Antigens in the Spontaneous Development of Autoimmunity in MRL- lpr Mice. The Journal of Immunology. 162(11). 6322–6330. 101 indexed citations

13.

Ellison, Cynthia A., et al.. (1998). DEPLETION OF NATURAL KILLER CELLS FROM THE GRAFT REDUCES INTERFERON-?? LEVELS AND LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-?? RELEASE IN F1 HYBRID MICE WITH ACUTE GRAFT-VERSUS-HOST DISEASE1. Transplantation. 66(3). 284–294. 15 indexed citations

14.

Kakkanaiah, V.N., Eric S. Sobel, Glen C. MacDonald, et al.. (1997). B cell genotype determines the fine specificity of autoantibody in lpr mice. The Journal of Immunology. 159(2). 1027–1035. 15 indexed citations

15.

Kakkanaiah, V.N., Glen C. MacDonald, Philip L. Cohen, & Robert A. Eisenberg. (1996). Suppression and Reversal ofgldDisease by Parabiosis with Normal Mice. Clinical Immunology and Immunopathology. 78(1). 6–13. 3 indexed citations

16.

Ellison, Cynthia A., Glen C. MacDonald, Edward S. Rector, & John G. Gartner. (1995). Gamma δ T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that γ δ T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. The Journal of Immunology. 155(9). 4189–4198. 38 indexed citations

17.

MacDonald, Glen C. & John G. Gartner. (1992). PREVENTION OF ACUTE LETHAL GRAFT-VERSUS-HOST DISEASE IN F1 HYBRID MICE BY PRETREATMENT OF THE GRAFT WITH ANTI-NK-1.1 AND COMPLEMENT. Transplantation. 54(1). 147–151. 19 indexed citations

18.

MacDonald, Glen C. & John G. Gartner. (1991). Natural Killer (NK) Cell Activity in Mice with Acute Graft‐Versus‐Host Reactions: Characterization of a Thy‐1⁺ NK‐Like Cell with a Broadened Spectrum of Lytic Activity in the Spleen and Lymph Nodes. Scandinavian Journal of Immunology. 33(5). 553–565. 11 indexed citations

19.

MacDonald, Glen C. & John G. Gartner. (1991). THE HOST/DONOR ORIGIN OF CELLS MEDIATING NK AND NK-LIKE CYTOTOXIC ACTIVITY IN F1 HYBRID MICE WITH ACUTE GRAFT-VERSUS-HOST REACTIONS. Transplantation. 52(1). 141–142. 5 indexed citations

20.

Zubrzycka‐Gaarn, Elizabeth E., Glen C. MacDonald, Laurie Phillips, A O Jorgensen, & David H. MacLennan. (1984). Monoclonal antibodies to the Ca2+ + Mg2+-dependent ATPase of sarcoplasmic reticulum identify polymorphic forms of the enzyme and indicate the presence in the enzyme of a classical high-affinity Ca2+ binding site. Journal of Bioenergetics and Biomembranes. 16(5-6). 441–464. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact